1-20 of 108
Julie Kanter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Association of Surgical Splenectomy and Venous Thromboembolism and Stroke in People with Sickle Cell Disease

Brendon Lee, Marisol Betensky, Alexander A Boucher, Alice J. Cohen, Robert M. Cronin, Payal C. Desai, Srila Gopal, Stephanie H. Guarino, Lewis L Hsu, Modupe Idowu, Julie Kanter, Sophie Lanzkron, Jane A. Little, Molly Mandernach, Deepa Manwani, Melissa McNaull, Sana Saif Ur Rehman, Kenneth Rivlin, Farzana A Sayani, John J Strouse, Marsha Treadwell, Trisha E. Wong, Rakhi P. Naik
Journal: Blood
Blood (2024) 144 (Supplement 1): 5308.
https://doi.org/10.1182/blood-2024-202700
Published: 2024
Journal Articles

Designing and Implementing a Standardized Electronic Health Record (EHR) Template for Transition of Care in Sickle Cell Disease (SCD)

Stephanie H. Guarino, Robin E Miller, Kenneth Rivlin, Mohan Madisetti, Akshat Jain, Jerome A Osheroff, Payal Desai, Julie Kanter, Sophie Lanzkron
Journal: Blood
Blood (2024) 144 (Supplement 1): 7548.
https://doi.org/10.1182/blood-2024-207769
Published: 2024
Journal Articles

Motixafortide for Hematopoietic Stem and Progenitor Cell Mobilization and Collection in Sickle Cell Disease

Alexis Kristine Leonard, Akshay Sharma, Yogindra Persaud, Parul Rai, Darla Pickett, Renee Massey, Neha Das Gupta, Subodh Selukar, Salem M. Akel, Leigh Poston, Yan Zheng, Ella Sorani, Irit Gliko Kabir, Mitchell J Weiss, Stephen Gottschalk, Julie Kanter, Matthew Hsieh, John Tisdale
Journal: Blood
Blood (2024) 144 (Supplement 1): 2100.1.
https://doi.org/10.1182/blood-2024-200330
Published: 2024
Journal Articles

Pharmacokinetics/Pharmacodynamics, Safety, and Efficacy of Crizanlizumab in Patients with Sickle Cell Disease Aged 6 to <12 Years: 2-Year Data from the Phase 2 Solace-Kids Study

Matthew M. Heeney, David C Rees, Slimane Allali, Isaac Odame, Rodolfo D Cançado, Adlette Inati, Elena Cela, Deborah Keefe, Evgeniya Reshetnyak, Velusamy Shanmuganathan Muthusamy, Lidiya Bebrevska, Michele L Nassin, Julie Kanter
Journal: Blood
Blood (2024) 144 (Supplement 1): 180.
https://doi.org/10.1182/blood-2024-207207
Published: 2024
Journal Articles

Evaluating High-Sensitivity Troponin Levels in Patients with Sickle Cell Disease Presenting to the Emergency Department

Abdelrhman Mohammed, Najibah Galadanci, Gerhard S Hellemann, Julie Kanter
Journal: Blood
Blood (2024) 144 (Supplement 1): 801.
https://doi.org/10.1182/blood-2024-209434
Published: 2024
Journal Articles

Participants with a History of Stroke in Lovotibeglogene Autotemcel (Lovo-cel) Clinical Trials

Jennifer J. Jaroscak, Julie Kanter, Robert I. Liem, Anjulika Chawla, Melissa A. Kinney, Ankit Lodaya, Lin Pan, Emily Sheldon-Waniga, Francis J. Pierciey, Jr., Alexis Thompson
Journal: Blood
Blood (2024) 144 (Supplement 1): 3576.
https://doi.org/10.1182/blood-2024-199642
Published: 2024
Journal Articles

Etavopivat Reduces Incidence of Vaso-Occlusive Crises in Patients with Sickle Cell Disease: HIBISCUS Trial Phase 2 Results through 52 Weeks

Sophia Delicou, Fuad El Rassi, Biree Andemariam, Miguel R. Abboud, Julie Kanter, Marilyn J. Telen, Jessie Githanga, Adlette Inati, Ibrahim Idris, Sunil Navani, Eric Wu, Andrew Eisenberger
Journal: Blood
Blood (2024) 144 (Supplement 1): 179.
https://doi.org/10.1182/blood-2024-204962
Published: 2024
Journal Articles

Short Term Health-Related Quality of Life Change in Adults with Sickle Cell Disease

Julie Kanter, Sophie Lanzkron, Sana Saif Ur Rehman, Jane A. Little, Megan M. Ullman, Randall Curtis, Nicole Crook, Jonathan C. Roberts, Derek Robertson, Joanne Wu, Michael B. Nichol
Journal: Blood
Blood (2024) 144 (Supplement 1): 7672.
https://doi.org/10.1182/blood-2024-208556
Published: 2024
Journal Articles

Establishing a Definition of Transition of Care in Sickle Cell Disease: National Alliance of Sickle Cell Disease Centers Consensus

Stephanie H. Guarino, Akshat Jain, Mohan Madisetti, Kenneth Rivlin, Payal Desai, Robert Hagar, Julie Kanter, Sophie Lanzkron, Deepa Manwani
Journal: Blood
Blood (2024) 144 (Supplement 1): 3622.
https://doi.org/10.1182/blood-2024-207698
Published: 2024
Journal Articles

Initial Results from the BEACON Clinical Study: A Phase 1/2 Study Evaluating the Safety and Efficacy of a Single Dose of Autologous CD34+ Base Edited Hematopoietic Stem Cells (BEAM-101) in Patients with Sickle Cell Disease with Severe Vaso-Occlusive Crises

Ashish O. Gupta, Akshay Sharma, Haydar Frangoul, Jignesh Dalal, Julie Kanter, Asif Alavi, John DiPersio, Mary Eapen, Jennifer J. Jaroscak, Ernesto Ayala, Edward D. Ziga, Stacey Rifkin-Zenenberg, Alex C. Minella, Guo Chen, Yinzhong Chen, Priya S. Chockalingam, Ling Lin, Marcelyne Joseney-Antoine, Leanne Ianniello, Beth Gardner, Adam J. Hartigan, Giuseppe Ciaramella, Sunita Goyal, Amy Simon, Alexis Thompson, Matthew M. Heeney
Journal: Blood
Blood (2024) 144 (Supplement 1): 513.
https://doi.org/10.1182/blood-2024-204888
Published: 2024
Journal Articles

An Update on Lovotibeglogene Autotemcel (Lovo-cel) Clinical Trials for Sickle Cell Disease (SCD) and Analysis of Early Predictors of Response to Lovo-Cel

Stacey Rifkin-Zenenberg, Julie Kanter, Melissa A. Kinney, Janet L. Kwiatkowski, Robert S. Nickel, Mark C. Walters, Suhag Parikh, Alexis Thompson, Anil P. George, Markus Mapara, Paul L. Martin, Anjulika Chawla, Ankit Lodaya, Lin Pan, Emily Sheldon-Waniga, Francis J. Pierciey, Jr., John Tisdale, Ashish O. Gupta
Journal: Blood
Blood (2024) 144 (Supplement 1): 511.
https://doi.org/10.1182/blood-2024-199743
Published: 2024
Journal Articles

Identifying Access to Mental Healthcare Services for Pediatric Patients Living with Sickle Cell Disease

Hannah Lebensburger, Julie Kanter, Donna Murdaugh
Journal: Blood
Blood (2024) 144 (Supplement 1): 395.
https://doi.org/10.1182/blood-2024-206271
Published: 2024
Journal Articles

Reduced Intensity Haploidentical Bone Marrow Transplantation in Adults with Severe Sickle Cell Disease: BMT CTN 1507

Adetola A. Kassim, Mark C. Walters, Mary Eapen, Nicole Ritzau, Madoc Smith, Melhem M. Solh, Christopher McKinney, Michael Nieder, Maureen Ross, Michael Kent, Ghada Abusin, Kanwaldeep K. Mallhi, Jorge Galvez Silva, Paul Shaughnessy, Julie Kanter, Hilary Haines, Rafic J Farah, Yasser Khaled, Allistair Abraham, Catherine M. Bollard, Kenneth R. Cooke, Josu de La Fuente, Rabi Hanna, Mary M. Horowitz, Lori C Jordan, Lakshmanan Krishnamurti, Eric Leifere, Kris Michael Mahadeo, Shalini Shenoy, Nicole M. Ritzau, Michael R. DeBaun, Robert A. Brodsky
Journal: Blood
Blood (2023) 142 (Supplement 2): LBA-4.
https://doi.org/10.1182/blood-2023-192022
Published: 2023
Journal Articles

Successful Implementation Trial to Improve Stroke Risk (TCD) Screening in Children with Sickle Cell Anemia: A Roadmap to Care Enhancement

Julie Kanter, Shannon Phillips, Alyssa M. Schlenz, Cathy Melvin, Robert J. Adams, Daniel Humphrey, Martina Mueller
Journal: Blood
Blood (2023) 142 (Supplement 1): 247.
https://doi.org/10.1182/blood-2023-187084
Published: 2023
Journal Articles

Socioeconomic Status and Risk of Stroke As Assessed By Transcranial Doppler: A Displace Study Secondary Analysis

Jeffrey G Edwards, Daniel Humphrey, Martina Mueller, Shannon Phillips, Morohuntodun O. Oni, Julie Kanter, Kira Bona, Natasha Archer
Journal: Blood
Blood (2023) 142 (Supplement 1): 5111.
https://doi.org/10.1182/blood-2023-187591
Published: 2023
Journal Articles

Efficacy, Safety, and Health-Related Quality of Life (HRQOL) in Patients with Sickle Cell Disease (SCD) Who Have Received Lovotibeglogene Autotemcel (Lovo-cel) Gene Therapy: Up to 60 Months of Follow-up

Julie Kanter, Alexis A. Thompson, Janet L. Kwiatkowski, Suhag Parikh, Markus Mapara, Stacey Rifkin-Zenenberg, Banu Aygun, Kimberly A. Kasow, Ashish O. Gupta, Lixin Zhang, Emily Sheldon-Waniga, Meghan Gallagher, Katiana Gruppioni, Anjulika Chawla, Heidi Elliot, Francis J. Pierciey, Mark C. Walters, John F. Tisdale
Journal: Blood
Blood (2023) 142 (Supplement 1): 1051.
https://doi.org/10.1182/blood-2023-174229
Published: 2023
Journal Articles

Safety and Pharmacokinetics of Recombinant ADAMTS13 in Patients with Sickle Cell Disease: A Phase 1 Randomized, Double-Blind, Placebo-Controlled Study

Julie Kanter, Parth Patwari, Payal Desai, Kenneth I. Ataga, Shelley E. Crary, Sophie Lanzkron, Joshua Field, Yu-Che Chung, Linda T. Wang, Björn Mellgård, Van Anh (Vika) Nguyen, Victor R. Gordeuk
Journal: Blood
Blood (2023) 142 (Supplement 1): 149.
https://doi.org/10.1182/blood-2023-189090
Published: 2023
Journal Articles

Steady-State Hemoglobin Is Associated with Self-Reported Ability to Perform Challenging Physical Function Activities, but Not Global Physical Function in Individuals with Sickle Cell Anemia

Elizabeth Linton, Jennifer Schrack, Julie Kanter, Deepa Manwani, Jane A. Little, Sophie Lanzkron
Journal: Blood
Blood (2023) 142 (Supplement 1): 3882.
https://doi.org/10.1182/blood-2023-188159
Published: 2023
Journal Articles

Primary Analysis of Spartan: A Phase 2 Trial to Assess the Efficacy and Safety of Crizanlizumab in Patients with Sickle Cell Disease Related Priapism

Modupe Idowu, Michael R. DeBaun, Arthur Burnett, Deepika S. Darbari, Soheir Adam, Alan Randall Anderson, Julie Kanter, Henny H. Billett, Darla K. Liles, Robert S. Nickel, Laura M. Decastro, Biree Andemariam, Gershwin Theophilus Blyden, Matthew M. Heeney, Poornima Ramadas, Morgan L. McLemore, Yogita Kolekar, Dramane Laine, Jincy Paulose, Rajendra Sarkar, Mary Beth Vignogna, Fuad El Rassi
Journal: Blood
Blood (2023) 142 (Supplement 1): 146.
https://doi.org/10.1182/blood-2023-179042
Published: 2023
Journal Articles

Displace Study Shows Poor Quality of Transcranial Doppler Ultrasound for Sickle Cell Stroke Screening: An Urgent Need for Standardized Reporting

Kimberly Davidow, Robin E. Miller, Shannon Phillips, Alyssa M. Schlenz, Martina Mueller, Monica L. Hulbert, Lewis Hsu, Neha Bhasin, Robert J. Adams, Julie Kanter
Journal: Blood
Blood (2023) 142 (Supplement 1): 3888.
https://doi.org/10.1182/blood-2023-177705
Published: 2023